Nemaura Medical Inc. NMRD
We take great care to ensure that the data presented and summarized in this overview for Nemaura Medical Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in NMRD
Top Purchases
Top Sells
About NMRD
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Insider Transactions at NMRD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2024
|
Arash Ghadar Ghadr Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$0
$0.14 P/Share
|
|
Jan 31
2022
|
Justin James Mclarney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,293
+50.0%
|
-
|
Last 12 Months Summary
| Open market or private purchase | 100K shares |
|---|